BRISTOL-MYERS SQUIBB ADDS ANALGESIC STRENGTH IN EUROPE WITH UPSA GROUP
This article was originally published in The Tan Sheet
BRISTOL-MYERS SQUIBB ADDS ANALGESIC STRENGTH IN EUROPE WITH UPSA GROUP acquisition on Sept. 20 for an undisclosed amount. UPSA Group, a privately held French OTC and prescription drug company, is the leading manufacturer and marketer of analgesics in France and Belgium, according to BMS.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC